John W. Babich
Präsident bei Ratio Therapeutics, Inc.
Aktive Positionen von John W. Babich
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | Direktor/Vorstandsmitglied | - | - |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Präsident | - | - |
Karriereverlauf von John W. Babich
Ehemalige bekannte Positionen von John W. Babich
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Noria Therapeutics, Inc.
Noria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, Noria Therapeutics, Inc. is a company that develops therapeutics. The company is based in New York, NY. The company was founded by John W. Babich. Noria Therapeutics was acquired by Bayer AG on June 03, 2021. | Gründer | - | - |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 04.06.2009 | - |
Vorstandsvorsitzender | 04.06.2009 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 04.06.2009 | - | |
Gründer | 17.05.2010 | - |
Ausbildung von John W. Babich
University of Southern California | Graduate Degree |
University of London | Doctorate Degree |
St. John's University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Noria Therapeutics, Inc.
Noria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, Noria Therapeutics, Inc. is a company that develops therapeutics. The company is based in New York, NY. The company was founded by John W. Babich. Noria Therapeutics was acquired by Bayer AG on June 03, 2021. | Commercial Services |
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | Health Technology |
- Börse
- Insiders
- John W. Babich
- Erfahrung